RPRD (Right Patient Right Drug) Diagnostics is a precision medicine company offering clinical pharmacogenomics (PGx) testing and analysis services to healthcare providers and pharmaceutical companies worldwide. The Company is the PGx reference lab of choice for the leading pediatric cancer centers in the nation, as ranked by US News and World Report for 2019-2020. Results from RPRD Diagnostic’s PGx tests are used by healthcare providers to support clinical decision-making, thereby improving patient outcomes and reducing costs. The company specializes in both comprehensive PGx and tailored panels, such as the CNT Panel for identification of leukemia patients at risk for toxicity from thiopurine drugs. These tests enable physicians to consider a patient’s unique genetic profile when recommending drug treatment.
Company Details
- Employees
- 10
- Address
- Wauwatosa, Wisconsin
- Phone
- 1 (414) 316-3097
- in****@****rdx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- rprdx.com
- Keywords
- Pharmacogenetics, Genotyping, DNA Sequencing, DNA Sequence Analysis, Pharmacogenomics, Precision Medicine.
- HQ
- Wauwatosa, Wisconsin
Rprd Diagnostics Questions
Rprd Diagnostics's helpline number is 1 (414) 316-3097
Rprd Diagnostics's website is rprdx.com
Rprd Diagnostics's LinkedIn profile is https://www.linkedin.com/company/rprdx
Rprd Diagnostics has
10 employees.
View email and phone details for 10
employees at Rprd Diagnostics.
Rprd Diagnostics's industry is
Biotechnology Research
Rprd Diagnostics's top competitors are
Pharmacogenomics Global Research Network (Pgrn),
Healthquist Inc.,
Oneome,
Bino Rhino, Llc,
Genentech,
D1asp0ra,
Kiji Therapeutics,
Vascugen,
Xiogenix,
Empirico.
Rprd Diagnostics's support email address is info@rprdx.com
Rprd Diagnostics's categories are Biotechnology Research
